Skip to main content
. 2013 Oct-Dec;17(4):627–635. doi: 10.4293/108680813X13794522667409

Table 4.

Pathology for Patients Undergoing RDP

Variable RDP (n = 40)
Benign/Low-grade neoplasms, n (%) 26 (65)
    Mucinous cystic neoplasm 3
    Serous cystadenoma 5
    Intraductal papillary mucinous neoplasm 6
    Pseudocyst 1
    Simple cyst 1
    Pancreatic neuroendocrine tumor 8
    Other 2
Malignant, n (%) 14 (35)
    Pancreatic ductal adenocarcinoma 10 (25)
    Intraductal papillary mucinous carcinoma 1
    Pancreatic neuroendocrine carcinoma 1
    Pancreatic acinar cell carcinoma 1
    Renal cell carcinoma 1
Lesion size (cm), median (IQR) 3.3 (2.4–5)
Length of resected pancreas (cm), mean (SD) 7.9 (2.8)
Positive margin, n (%) 3 (7.5)
Number of lymph nodes evaluated, median (IQR) 4.5 (0.75–7.25)
Patients with positive lymph nodes, n (%) 4 (10)